Clinical Trial Update: Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ALX-0600 for safety and efficacy in active Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• ALX-0600

Snippet

Sponsor: Shire | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED